RCKT Latest Headlines

Rocket Pharma upgraded at Needham as FDA OKs pivotal trial design

at seekingalpha.com (Wed, 16-Sep 11:18 AM)

Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Veracyte (VCYT) and Rocket Pharmaceuticals (RCKT)

at www.tipranks.com (Wed, 16-Sep 8:50 AM)

Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA), Rocket Pharmaceuticals (RCKT) and Ascendis Pharma (ASND)

at www.tipranks.com (Wed, 16-Sep 5:00 AM)

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT) and Rocket Pharmaceuticals (RCKT)

at www.tipranks.com (Tue, 15-Sep 12:30 PM)

Rocket Pharmaceuticals: FDA Alignment De-Risks Danon Program, Safety Data Strengthens Outlook as Buy Rating Reiterated with Unchanged $15 Price Target

at www.tipranks.com (Tue, 15-Sep 11:15 AM)

Chardan Capital Keeps Their Buy Rating on Rocket Pharmaceuticals (RCKT)

at www.tipranks.com (Tue, 15-Sep 9:55 AM)

Rocket Pharmaceuticals advances pivotal Danon disease trial

at www.tipranks.com (Tue, 15-Sep 7:27 AM)